Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Antibodies
61%
Allergen
60%
COVID-19
56%
Receptor Binding
44%
Neutralizing Antibody
40%
T Cell
31%
Natural Killer Cell
24%
B Cell
24%
Omicron Coronavirus Variant
22%
Cell Surface
22%
Immunocompetent Cell
22%
Antibody Response
22%
Immunoglobulin E
21%
CD19
21%
Wild Type
20%
Hepatitis B Virus
20%
Seroconversion
20%
Macropinocytosis
20%
CD69
20%
Allele
20%
Lymphocyte Activation
20%
Glycopeptide Antibiotic
20%
Cytokine
20%
Mycobacterium Avium Complex
20%
Multiple Myeloma
20%
Antigen-Presenting Cell
20%
Allergen Immunotherapy
20%
Beta1 Interferon
20%
Tyrosine
20%
Autoantibodies
20%
CD3 Antigen
19%
Immunology
19%
Immunotherapy
16%
Antigen Presenting Cell
16%
Immune Dysregulation
13%
Spike
10%
Bagg Albino Mouse
8%
Pomalidomide
8%
Memory B Cell
8%
Immunocompromised Patient
8%
Virus Nucleocapsid
8%
Vaccination Schedule
8%
Cell Line
7%
T Cell Proliferation
7%
Immunoglobulin G
6%
Cytoskeleton
6%
Germline Mutation
6%
Filopodia
6%
Germ Cell
6%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
40%
Antibodies
40%
Immunosuppressive Treatment
33%
Neoplasm
22%
COVID-19
22%
T Cell
20%
Receptor Binding
20%
Allergology
20%
Immunology
20%
Neutralizing Antibody
20%
Macropinocytosis
20%
Natural Killer Cell
20%
Nanoparticle
20%
Allergen
20%
Multiple Myeloma
20%
Cell Surface
20%
Antigen Presenting Cell
20%
Seroconversion
20%
COVID-19 Vaccination
20%
Leukemia
20%
Flow Cytometry
20%
Beta1 Interferon
20%
Infection
18%
Immunocompromised Patient
18%
Maintenance Therapy
13%
COVID-19 Vaccine
13%
Side Effect
13%
Pomalidomide
13%
Passive Immunization
8%
Active Immunization
8%
Vitronectin
8%
T Cell Proliferation
8%
Immunity
6%
Immune Response
6%
Interleukin 2
6%
Immunomodulatory Drug
6%
Immunopathology
6%
CD3 Antigen
6%
Myeloma Cell
6%
Angiogenesis
6%
Interleukin 13
6%
Cytokine Production
6%
Cell Growth
6%
Galectin 1
6%
Immunogenic Cell Death
6%
Cell Line
6%
In Vitro
5%
Biological Product
5%
Drug Therapy
5%
Biochemistry, Genetics and Molecular Biology
Binding Domain
40%
Wild Type
40%
SARS Coronavirus
40%
Receptor Binding
40%
Antibodies
24%
Neutralizing Antibody
21%
Interleukin 13
20%
IFNAR1
20%
Chimeric Protein
20%
Lymphocyte Activation
20%
Flow Cytometry
20%
Tyrosine Kinase 2
20%
Hepatitis B Virus
20%
Autoantibodies
20%
Cohort Study
20%
Coronavirinae
20%
T Cell
10%
Cytotoxicity
10%
Tumor Progression
10%
Natural Killer Cell
10%
Ovalbumin
10%
CD8
10%
Titer
8%
Proinflammatory Cytokine
6%
Germline Mutation
6%
Filopodia
6%
Cytoskeleton
6%
RNA Sequencing
6%
Galectin-1
6%
